JNJ vs LABFF: Which Is the Better Dividend Stock?
As of June 2026, LABFF (Laboratorios Farmaceuticos Rovi, S.A.) screens as the stronger dividend stock, winning 5 of 7 head-to-head metrics. LABFF offers the higher yield at 23.77%, JNJ has the higher dividend-safety score, and LABFF trades at the larger discount to fair value (-1%).
| Metric | JNJ | LABFF |
|---|---|---|
| Forward yield | 2.19% | 23.77% |
| Annual dividend | $5.36 | $21.54 |
| Payout ratio | 60% | 0% |
| Years of growth | 55 yr | 0 yr |
| 5-yr dividend growth | 5.2% | — |
| 5-yr total return | 33% | 34% |
| Dividend safety score | 89 (A) | 42 (D) |
| Fair value estimate | $213.72 | $89.89 |
| Upside to fair value | -6% | -1% |
| Frequency | quarterly | monthly |
| Market cap | $589.5B | $4.6B |
| P/E ratio | 28.4 | 28.9 |
Higher yield
LABFF
23.77%
Safer dividend
JNJ
Grade A
Faster growth
JNJ
5.2%
Better value
LABFF
-1% upside
JNJ vs LABFF — FAQ
Related comparisons
See more dividend stock comparisons · data refreshes daily · for informational purposes only, not investment advice.